Patents by Inventor Karl S.A. Vallin

Karl S.A. Vallin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bis-(sulfonylamino) derivatives for use in therapy
    Patent number: 9145380
    Abstract: The invention provides compounds of formula (I) wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: September 29, 2015
    Assignee: Astrazeneca AB
    Inventors: Johan Bylund, Maria E Ek, Ylva Gravenfors, Gunnar Nordvall, Alexander Minidis, Karl S. A Vallin, Jenny Viklund, Jörg Holenz, Stefan Von Berg, Daniel Sohn
  • Bis-(Sulfonylamino) derivatives for use in therapy
    Publication number: 20100331321
    Abstract: The invention provides compounds of formula (I) wherein R1,R3,L1,L2,G1,G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.
    Type: Application
    Filed: December 18, 2008
    Publication date: December 30, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Johan Bylund, Maria E. Ek, Ylva Gravenfors, Jorg Holenz, Alexander Minidis, Gunnar Nordvall, Daniel Sohn, Karl S.A. Vallin, Jenny Viklund, Stefan Von Berg
  • Bis-(Sulfonylamino) Derivatives in Therapy 205
    Publication number: 20090163586
    Abstract: The invention provides compounds of formula (I) wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.
    Type: Application
    Filed: December 17, 2008
    Publication date: June 25, 2009
    Applicant: AstraZeneca AB
    Inventors: Johan Bylund, Maria E. Ek, Ylva Gravenfors, Jorg Holenz, Alexander Minidis, Gunnar Nordvall, Daniel Sohn, Karl S.A. Vallin, Jenny Viklund, Stefan Von Berg